← All trials
NCT03441958
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 7, 2018
- Primary completion
- Mar 1, 2022
- Completion date
- Mar 1, 2024
- First posted
- —
- Last posted
- —
- Enrollment
- 20
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Ciusss de L'Est de l'Île de MontréalLead sponsor
- Centre de Commercialisation en Immunothérapie du Cancer (C3i)Collaborator
- ExcellTheraCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.